Keisha Perry, PA
Physician Assistant · Surprise, AZNPI 1447628458
Payments from drug & device makers
Across 37 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$304
- Valinor Pharma, LLC$163
- Astellas Pharma US Inc$39
- Teva Pharmaceuticals USA, Inc.$39
- Takeda Pharmaceuticals U.S.A., Inc.$30
- Abbott$26
- plus $58 from 3 others
What the payments were for
- Food & beverage$658100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $304 |
| Valinor Pharma, LLC | 7 | $163 |
| Astellas Pharma US Inc | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Abbott | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Boston Scientific | 1 | $19 |
How this compares
$658 in reported general payments places this provider in the 60th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 50 | $28,862 |
| MovantikNaloxegol Oxalate | 40 | $17,827 |
| Xtampza ErOxycodone Myristate | 45 | $10,829 |
| Oxycodone Hcl | 562 | $10,405 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 234 | $8,260 |
| Morphine Sulfate ErMorphine Sulfate | 317 | $7,731 |
| Hysingla ErHydrocodone Bitartrate | 19 | $7,195 |
| Lidocaine | 81 | $6,786 |
| Tizanidine Hcl | 198 | $4,533 |
| Gabapentin | 326 | $4,076 |
| Morphine Sulfate | 131 | $3,414 |
| Diclofenac Sodium | 91 | $3,201 |
| Hydromorphone Hcl | 173 | $3,151 |
| Pregabalin | 152 | $2,758 |
| Naloxone Hcl | 39 | $2,512 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Surprise
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
- Nicole StokerTucson$61K
- Micah LasleyPhoenix$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.